雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Clinical Study on Atraxin (=Meprobamate) a New Tranquilizor Yoshio Kaneda 1 , Haruo Inoue 1 , Takeo Tamura 1 1Department of Neuropsychiatry, Tokyo Medical and Dental University. School of Medicine pp.194-199
Published Date 1957/3/1
DOI https://doi.org/10.11477/mf.1406200556
  • Abstract
  • Look Inside

The clinical effect of Meprobamate (2・2-methyl-n-Propyl-1・3-propanediol dicarbamate) Atraxin (made by Daiichi Seiyaku Co. Ltd.), which was applied as so-called tranquilizor to psy choneurotic patients, was described in the present report.

Material and Method: -

50 Patients being in various psychoneurotic states were examined. We usually administer this drug to the patients in dosage 1.2~1.6 gm. at 3-4 times a day and kept this dosage for several weeks or more.

Result: - Remarkably improved……9 cases……22.5%

Relatively improved……17 cases……42.5%

Total……26 cases……65.0%

Not improved……14 cases……35.0%

Unknown……10 cases

It appeared that Atraxin had a good influ-ence on anxiety state, tension state and sleep-lessness, furthermore developed from above states, this drug let some patients have a will for life. Generally speaking, this drug is the most favourable for psychoneurosis and also for some troubleness after head injuries and simple sleeplessness, however there was no effect for schizophrenia, some psychopathes (habitual taker of hypnotics etc.), as expected.

Side Reaction: -


Copyright © 1957, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 2185-405X 印刷版ISSN 0006-8969 医学書院

関連文献

もっと見る

文献を共有